Sharemaestro Newsreel

Cardinal Health Q4 Results: EPS Expected At $2.42, Revenue Hits $65.1 Billion

Cardinal Health Inc. is expected to report Q4 earnings with an EPS of $2.42 and revenue of $65.11 billion, reflecting significant year-over-year growth. The company recently acquired Adapthealth’s diabetes business and Strive Medical for $360 million, aiming to expand its specialized care segments. Analyst …

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6

Baird has downgraded Accendra Health Inc. to a Neutral rating from its previous Outperform rating. Concurrently, the investment firm significantly reduced its target price for Accendra Health Inc. shares to $1.50 from the prior $6.00. This adjustment indicates a revised outlook on the company's …

Should Henry Schein’s (HSIC) Upgraded 2026 Outlook and New Structure Require Action From Investors?

Henry Schein (HSIC) recently reported strong Q2 2026 results, raising its full-year sales growth guidance to 4.5%–5.5% and unveiling a new leadership structure and integrated global supply chain. While the upgraded outlook and new structure aim to improve efficiency and execution, they also introduce …

Cencora (COR) Posts Strong Q3 Earnings, Is The 9% Upside Enough?

Cencora (COR) recently reported strong Q3 2026 results with increased sales, net income, and EPS, alongside share repurchases and a new dividend. Despite a 22.81% 90-day return, the stock is down 5.43% year-to-date, though its 5-year total shareholder return is 179.97%. Simply Wall St's …

MCKESSON CORP SEC Filing (Aug 10, 2026)

This article details an SEC Form 144 filing by McKesson Corp (MCK) on August 10, 2026. The filing indicates a proposed sale of 301 shares of common stock, acquired through an RSU award on July 30, 2025, with an aggregate market value of $268,589.00. …

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation QDEL delivered adjusted earnings per share (EPS) of 13 cents in second-quarter 2026, up 8.3% year over year. The figure beat the Zacks Consensus Estimate by 425%. The adjustments include expenses related to the amortization of intangibles, acquisition and integration costs, among …

Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline

Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.60 in the second quarter of 2026, up 3.2% year over year. The figure beat the Zacks Consensus Estimate by 15.9%. The adjustments include expenses related to the amortization of intangible assets and …

Accendra Health outlines $2.45B-$2.55B 2026 revenue and $300M-$320M adjusted EBITDA amid cost cuts and CEO retirement plan

Earnings Call Insights: Accendra Health (ACH) Q2 2026 MANAGEMENT VIEW * "Before I dive into our second quarter results and the outlook for the balance of the year, I'd like to take a moment to address the announcement included in today's press release that …

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

Inogen, Inc. INGN reported breakeven earnings for second-quarter 2026, compared to the year-ago period's adjusted loss of 2 cents per share. GAAP loss per share of 14 cents, narrower than the year-ago loss of 15 cents. The figure beat the Zacks Consensus Estimate by …

iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised

iRhythm Holdings, Inc. IRTC reported adjusted earnings per share of 58 cents in the second quarter of 2026, against an adjusted loss per share of 32 cents a year ago. The figure beat the Zacks Consensus Estimate by 5900%. GAAP loss per share for …

ACCENDRA HEALTH 2026: Revenue $613.23M, EPS ($1.16) — 10-Q Summary

ACCENDRA HEALTH (ACH) reported its second-quarter 2026 results, with net revenue of $613.23 million and a diluted loss per share of ($1.16). This represents a decline in revenue compared to the prior year, primarily due to the loss of a major commercial payor contract, …

Accendra Health Reports Lower Q2 Revenue, Sets 2026 Guidance; Adopts Tax Asset Plan; Stock Down

(RTTNews) - Accendra Health, Inc. (ACH) reported financial results for the second quarter ended June 30, 2026, showing a decline in revenue, as the company continues its transition following separation from Owens & Minor. Revenue for the quarter came in at $613.2 million, down …

Accendra Health CEO to retire by end of the year

Accendra Health President and CEO Edward A. Pesicka announced his plan to retire by the end of the year after leading the company for over seven years, including its rebranding from Owens & Minor. The board is evaluating successors, and Pesicka may stay on …

Cardinal Health earnings ahead: Can profit growth continue?

Cardinal Health is set to report its fiscal fourth-quarter results, with analysts expecting $2.42 EPS on $65.03 billion revenue, representing significant year-over-year growth. Investors will focus on the sustainability of margin expansion and revenue momentum, especially given the company's premium valuation and recent stock …

Should Value Investors Buy Henry Schein (HSIC) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

MCKESSON CORP : JP MORGAN RAISES TARGET PRICE TO $1042 FROM $1015

JP Morgan has increased its target price for McKesson Corp (MCK.N) to $1042 from $1015. This update was reported by Reuters on August 10, 2026. The article notes that the content reflects the author's opinion and is not investment advice.

Accendra Health tumbles 25% on Q2 miss and weak guidance

Accendra Health (NYSE:ACH) reported second-quarter results that missed analyst expectations for both earnings per share and revenue, leading to a 24.6% drop in shares. The company also issued full-year 2026 revenue guidance below consensus estimates. In response, Accendra Health adopted a Tax Asset Preservation …

Accendra Health CEO Ed Pesicka Plans Retirement as Board Begins Successor Search

Accendra Health (NYSE: ACH) President and CEO Edward A. Pesicka announced his plan to retire by the end of 2026 after over seven years with the company. The board has initiated a search for his successor, drawing from an existing succession plan. Pesicka cited …

6,734 Shares in McKesson Corporation $MCK Bought by Deane Retirement Strategies Inc.

Deane Retirement Strategies Inc. recently acquired 6,734 shares of McKesson Corporation, valued at approximately $5.1 million, making it 2.2% of their portfolio. This investment comes as McKesson reported strong Q1 earnings, exceeding expectations with $9.93 EPS and $105.38 billion in revenue, driven by specialty …

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 10.70% Upside Potential with Solid Revenue Growth

Empowered Funds LLC Lowers Holdings in Henry Schein, Inc. $HSIC

Empowered Funds LLC significantly reduced its stake in Henry Schein, Inc. by 59.2% in the first quarter, selling 16,735 shares and retaining 11,551 shares valued at $851,000. Despite this, Henry Schein exceeded quarterly earnings expectations with $1.27 EPS and $3.46 billion in revenue, and …

111 Inc (YI) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for 111 Inc (YI), detailing future EPS, revenue, net profit, and EBIT growth estimates. It also includes current stock information such as price, market cap, and P/E TTM, alongside a comparison with peer companies in the pharmaceuticals sector. …

Henry Schein (HSIC) Lifts Outlook As Earnings Improve While Valuation Looks Full

McKesson Corporation $MCK Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in McKesson Corporation, selling 48.9% of its shares. Despite this, McKesson has shown strong financial performance, exceeding earnings and revenue expectations, and raising its fiscal 2027 adjusted EPS guidance. The company is also increasing shareholder returns …

Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow

Cardinal Health (CAH) is set to announce its Q2 earnings tomorrow before market hours. Analysts expect revenue growth of 8.7% year-on-year, an improvement from flat revenue last year. The company previously missed revenue expectations but beat full-year EPS guidance.

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Barrick Mining Corporation (B [https://seekingalpha.com/symbol/B]) * Medical Properties Trust (MPT [https://seekingalpha.com/symbol/MPT]) * Seadrill Limited (SDRL [https://seekingalpha.com/symbol/SDRL]) * monday.com Ltd. (MNDY [https://seekingalpha.com/symbol/MNDY]) * Village Farms International (VFF [https://seekingalpha.com/symbol/VFF]) Other earnings slated for release before Monday's …

Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more

[Business Person Reviewing Quarterly Report During Meeting in Office Setting] The second full week of August features a diverse earnings slate spanning AI infrastructure, semiconductors, space technology, healthcare, financials, and consumer names, with Super Micro Computer (SMCI [https://seekingalpha.com/symbol/SMCI]), Nebius (NBIS [https://seekingalpha.com/symbol/NBIS]), Cisco Systems (CSCO …

Cencora, Inc. (COR) Stock Forecasts

This article provides a stock forecast for Cencora, Inc. (COR), a major pharmaceutical wholesaler. It highlights a Morningstar report from August 5, 2026, which discusses Cencora's earnings growth and market confidence recovery. The report also positions Cencora among leading domestic pharmaceutical wholesalers.

2 key checks on AI infrastructure and inflation: What to watch this week

The stock market's first week after the Big Tech earnings extravaganza went about as well as any investor could have hoped. The initial mixed bag of earnings gave way to general bullishness as AI's spending worries receded somewhat. And with Friday's jobs report surprise, …

Henry Schein (NASDAQ:HSIC) Stock Rating Lowered by Wall Street Zen

McKesson Q1 Earnings Call Highlights

Key Points Interested in McKesson Corporation? Here are five stocks we like better. McKesson raised its fiscal 2027 outlook after a stronger-than-expected first quarter, with revenue up 8% to $105.4 billion and adjusted EPS up 20% to $9.93. The company now expects adjusted EPS …

Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week

Major healthcare heavyweights, including Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), Merck (MRK [https://seekingalpha.com/symbol/MRK]), and Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]), reported their quarterly earnings this week, pushing the healthcare sector into positive territory after five consecutive sessions of losses. The State Street Health Care Select Sector SPDR ETF [https://seekingalpha.com/symbol/XLV] …

Is Cardinal Health (CAH) Undervalued On Strong Earnings Expectations?

Cardinal Health (CAH) is currently considered undervalued, with a fair value of $250.53 against a share price of $236.40, driven by expectations of strong quarterly earnings and revenue. While analysts have a consensus price target aligning with this fair value, the stock's P/E ratio …

Earnings Scoreboard: 86% of S&P 500 reporting firms top EPS estimates as 79% post Y/Y profit growth

[Rolled newspaper with the headline Quarterly Results] Zerbor S&P 500 earnings activity accelerated this week, with more than 130 index members reporting quarterly results that provided key insights into corporate margin health, spending trends, and overall macroeconomic strength. EARNINGS ROUNDUP: * BOTTOM LINE (EPS): …

McKesson Stock: Solid Q1 Earnings And Management Execution (Upgrade) (NYSE:MCK)

McKesson reported strong Q1 results, with EPS increasing by 20% and revenues by 7.7%, leading to a modest raise in FY27 EPS guidance. The company's streamlining efforts through the Wellverse spin-off and prior divestitures may justify a premium valuation despite a projected deceleration in …

The Bull Case For Cencora (COR) Could Change Following Raised EPS Outlook And Bigger Buybacks And Dividend

Cencora recently announced strong third-quarter 2026 results, including higher sales and net income, alongside an increased adjusted EPS outlook and expanded revolving credit capacity. The company is actively returning capital to shareholders through buybacks and dividends, while also monitoring a potential MWI Animal Health–Covetrus …